RAPH
Raphael Pharmaceutical Inc. SEC filings
Every EDGAR filing for Raphael Pharmaceutical Inc. (RAPH), newest first, with AI summaries and stories.
- Ticker
- RAPH
- CIK
- 1415397
- Latest filing
- Sep 1
Next: 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
8-KRaphael Pharmaceutical Inc.RAPHLIVE 10-QRaphael Pharmaceutical Inc.RAPHLIVE 8-KRaphael Pharmaceutical Inc.RAPHLIVE 10-QRaphael Pharmaceutical Inc.RAPHLIVE 4Raphael Pharmaceutical Inc.RAPHLIVE Hayon Igal Louria, insider filing for RAPH
Hayon Igal Louria, reporting
10-KRaphael Pharmaceutical Inc.RAPHLIVE 8-KRaphael Pharmaceutical Inc.RAPHLIVE 10-QRaphael Pharmaceutical Inc.RAPHLIVE Raphael Pharmaceutical Inc. (RAPH) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.